BIOVIE INC
For the period ended Jun 30, 2024. Filed Sep 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 30, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Indicates a management contract or compensatory plan or arrangement
- Filed herewith.
** Furnished herewith.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: September 30, 2024 | BIOVIE INC. | ||
|---|---|---|---|
| By: | /s/ Cuong Do | ||
| Name: | Cuong Do | ||
| Title: | Chief Executive Officer (Principal Executive Officer) | ||
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Cuong Do and Joanne Wendy Kim, and each of them acting individually and without the other, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments, exhibits thereto and other documents in connection therewith) to this Report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them individually, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.
| Person | Capacity | Date |
|---|---|---|
| /s/ Cuong Do | Chief Executive Officer | September 30, 2024 |
| Cuong Do | (Principal Executive Officer) | |
| /s/ Joanne Wendy Kim | Chief Financial Officer | September 30, 2024 |
| Joanne Wendy Kim | (Principal Financial Officer) | |
| /s/ Jim Lang | Director | September 30, 2024 |
| Jim Lang | ||
| /s/ Michael Sherman | Director | September 30, 2024 |
| Michael Sherman | ||
| /s/ Richard J. Berman | Director | September 30, 2024 |
| Richard J. Berman | ||
| /s/ Robert Hariri | Director | September 30, 2024 |
| Robert Hariri | ||
| /s/ Sigmund Rogich | Director | September 30, 2024 |
| Sigmund Rogich | ||
Index to Financial Statements
| Report of Independent Registered Public Accounting Firm – EisnerAmper LLP (PCAOB Number 274) | F-2 |
|---|---|
| Financial Statements: | |
| Balance Sheets | F-4 |
| Statements of Operations and Comprehensive Loss | F-5 |
| Statements of Changes in Stockholders’ Equity | F-6 |
| Statements of Cash Flows | F-7 |
| Notes to Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.